Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agusti Alentorn

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Bulletin De L'Academie Nationale De Medecine|June 7, 2018
[Targeted therapy in glioblastoma: update and perspectives]Ahmed Idbaih, Alberto Duran-Peña, Agusti Alentorn
Handbook of Clinical Neurology|March 8, 2016
Presenting signs and symptoms in brain tumorsAgusti Alentorn, Khê Hoang-Xuan, Tom Mikkelsen
Current Opinion in Neurology|September 19, 2017
Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?Louis Royer-Perron, Khê Hoang-Xuan, Agusti Alentorn
Current Opinion in Oncology|September 16, 2015
Recent developments and controversies in primary central nervous system lymphomaAndreas F Hottinger, Agusti Alentorn, Khê Hoang-Xuan
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 26, 2019
Intrathecal Trastuzumab as a Potential Cause of Drug-Induced Aseptic MeningitisEvangelia Pappa, Rosa Conforti, Khê Hoang-Xuan, et al.
Journal of Neuro-Oncology|April 28, 2018
Pazopanib efficacy in recurrent central nervous system hemangiopericytomasCaroline Apra, Agusti Alentorn, Karima Mokhtari, et al.
Annals of Clinical and Translational Neurology|December 28, 2019
Gut microbiome alterations in anti-NMDA receptor encephalitis: caveats for result interpretationGiulia Berzero, Dimitri Psimaras, Nicolas Weiss, et al.
Current Treatment Options in Neurology|July 21, 2019
Treatment of Primary Central Nervous System Lymphoma in Immunocompetent PatientsYtel Garcilazo-Reyes, Agusti Alentorn, Alberto Duran-Pena, et al.
Expert Review of Molecular Diagnostics|September 24, 2015
Emerging circulating biomarkers in glioblastoma: promises and challengesMehdi Touat, Alberto Duran-Peña, Agusti Alentorn, et al.
International Journal of Molecular Sciences|December 30, 2020
Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association StudiesIsaias Hernández-Verdin, Karim Labreche, Marion Benazra, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Bulletin De L'Academie Nationale De Medecine|June 7, 2018
[Targeted therapy in glioblastoma: update and perspectives]Ahmed Idbaih, Alberto Duran-Peña, Agusti Alentorn
Handbook of Clinical Neurology|March 8, 2016
Presenting signs and symptoms in brain tumorsAgusti Alentorn, Khê Hoang-Xuan, Tom Mikkelsen
Current Opinion in Neurology|September 19, 2017
Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?Louis Royer-Perron, Khê Hoang-Xuan, Agusti Alentorn
Current Opinion in Oncology|September 16, 2015
Recent developments and controversies in primary central nervous system lymphomaAndreas F Hottinger, Agusti Alentorn, Khê Hoang-Xuan
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 26, 2019
Intrathecal Trastuzumab as a Potential Cause of Drug-Induced Aseptic MeningitisEvangelia Pappa, Rosa Conforti, Khê Hoang-Xuan, et al.
Journal of Neuro-Oncology|April 28, 2018
Pazopanib efficacy in recurrent central nervous system hemangiopericytomasCaroline Apra, Agusti Alentorn, Karima Mokhtari, et al.
Annals of Clinical and Translational Neurology|December 28, 2019
Gut microbiome alterations in anti-NMDA receptor encephalitis: caveats for result interpretationGiulia Berzero, Dimitri Psimaras, Nicolas Weiss, et al.
Current Treatment Options in Neurology|July 21, 2019
Treatment of Primary Central Nervous System Lymphoma in Immunocompetent PatientsYtel Garcilazo-Reyes, Agusti Alentorn, Alberto Duran-Pena, et al.
Expert Review of Molecular Diagnostics|September 24, 2015
Emerging circulating biomarkers in glioblastoma: promises and challengesMehdi Touat, Alberto Duran-Peña, Agusti Alentorn, et al.
International Journal of Molecular Sciences|December 30, 2020
Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association StudiesIsaias Hernández-Verdin, Karim Labreche, Marion Benazra, et al.
Pageof 7